Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Cell Separation Market Size & Growth Forecast 2027–2036, By Segments (Cell Type, Technique, End-Use, Application, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 3853| Published Date: Aug-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Cell Separation Market size was worth USD 11.2 billion in 2026 and is expected to grow at a 10.36% CAGR between 2027 and 2036, reaching USD 30.01 billion by 2036. The industry revenue for 2027 is calculated at USD 12.18 billion.

Base Year Value (2026)
USD 11.2 billion
CAGR (2027-2036)
10.36%
Forecast Year Value (2036)
USD 30.01 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Cell Separation Market Intelligence Snapshot

Regional Market Dynamics

  • North America captured a 38.73% share in 2026, driven by strong biotechnology infrastructure, research funding, and consistent use of cell separation tools in clinical and laboratory workflows.
  • Asia Pacific is projected to grow at an 11.31% CAGR, supported by expanding biomedical research capacity, biopharmaceutical investment, and rising adoption of cell processing technologies.

Segment Momentum

  • Animal cells held a 56.57% share in 2026 due to their extensive use in routine laboratory workflows, preclinical research, and established experimental models supported by standardized protocols and consistent availability.
  • Surface marker techniques are growing fastest because they enable more precise isolation of specific cell populations, supporting targeted research applications that require higher-purity samples and greater analytical accuracy.

Market Expansion Drivers

  • Rising biologics and personalized medicine demand increasing need for advanced cell isolation technologies.
  • Expanding cancer and infectious disease research driving adoption of high-throughput cell separation systems.
  • Growing biotechnology startup investments accelerating innovation in automated cell processing platforms.

Leading Market Participants

  • Major companies in the cell separation market include Thermo Fisher Scientific Inc. (United States), Danaher Corporation (United States), Becton, Dickinson and Company (United States), STEMCELL Technologies Inc. (Canada), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (United States), Terumo Corporation (Japan), Agilent Technologies, Inc. (United States), Corning Incorporated (United States), Akadeum Life Sciences, Inc. (United States).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 11.2 billion
  • 2027 Estimated Market Size: USD 12.18 billion.
  • Projected Market Size: USD 30.01 billion by 2036
  • Growth Forecast: 10.36% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Animal Cells (Cell Type) | Centrifugation (Technique) | Research Laboratories and Institutes (End-Use) | Biomolecule Isolation (Application) | Consumables (Product)
  • Emerging Opportunity Segment: Human Cells (Cell Type) | Surface Marker (Technique) | Biotechnology and Biopharmaceutical Companies (End-Use) | Biomolecule Isolation (Application) | Instruments (Product)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising biologics and personalized medicine demand increasing need for advanced cell isolation technologies

The growing development of biologics and personalized therapies is driving the cell separation market as researchers and biopharmaceutical manufacturers require reliable methods to isolate specific cell populations for research, development, and therapeutic applications. Cell separation enables the enrichment or purification of target cells while reducing unwanted populations, which is important for studying cellular characteristics and developing treatments tailored to individual biological profiles. Increasing complexity in cell-based research is also creating demand for technologies that deliver higher purity and reproducibility while preserving cell viability. These requirements are encouraging wider use of advanced separation techniques across research laboratories and biopharmaceutical workflows.

Expanding cancer and infectious disease research driving adoption of high-throughput cell separation systems

Growing research activity focused on cancer and infectious diseases is supporting the cell separation market by increasing the need to isolate and characterize distinct cell populations from complex biological samples. Researchers use separated cells to investigate disease mechanisms, immune responses, biomarkers, and treatment effects, creating demand for efficient workflows capable of processing large numbers of samples. High-throughput systems can improve laboratory productivity by automating repetitive separation processes while maintaining consistency across experiments. Increasing reliance on cellular analysis in disease research is therefore strengthening demand for scalable separation platforms and associated laboratory technologies.

Growing biotechnology startup investments accelerating innovation in automated cell processing platforms

Increasing investment in biotechnology startups is encouraging technological development across the cell separation market, particularly in automated platforms designed to improve the efficiency and reproducibility of cell processing. Emerging biotechnology companies are developing workflows that integrate separation with other laboratory steps, reducing manual handling and supporting more standardized processing. Automation can also improve scalability for research programs progressing from early discovery toward larger development workflows by enabling consistent treatment of biological samples. Greater availability of investment for cell and gene therapy, biologics, and advanced research technologies is supporting experimentation with more integrated cell processing systems.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising biologics and personalized medicine demand increasing need for advanced cell isolation technologies 2.10% High North America, Asia Pacific High Near Term
Expanding cancer and infectious disease research driving adoption of high-throughput cell separation systems 1.90% High North America, Europe High Mid Term
Growing biotechnology startup investments accelerating innovation in automated cell processing platforms 1.50% Moderate Asia Pacific, North America Emerging Long Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Cell Separation Market
Largest Region
North America
38.73% Market Share in 2026

North America (Largest Region)

North America dominated the cell separation market with a 38.73% share in 2026, benefiting from a strong biotechnology and life sciences ecosystem and extensive use of cell-based research and advanced biomedical applications. Demand for efficient cell isolation and purification is supported by research in areas such as regenerative medicine, immunology, cancer research, and biopharmaceutical development. Well-developed laboratory infrastructure, substantial investment in life sciences research, and increasing use of sophisticated cell analysis workflows are contributing to the region's market leadership.

Asia Pacific (Fastest-Growing Region)

Asia Pacific represents the fastest-growing regional market, supported by expanding biotechnology capabilities, increasing biomedical research activity, and growing investments in cell-based therapies. Improvements in laboratory infrastructure are enabling wider adoption of specialized cell separation technologies across research and clinical environments. Rising interest in regenerative medicine, personalized healthcare, and advanced bioprocessing is further increasing the need for reliable cell isolation and purification, strengthening the region's growth prospects.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Bioprocess Innovation Focus

Germany advances cell separation technologies through strong biopharmaceutical manufacturing and life sciences research activities. German laboratories and manufacturers increasingly deploy automated platforms that support high-purity cell isolation for research and clinical production workflows.

France 🇫🇷

Translational Research Applications

France promotes adoption of cell separation technologies across biomedical research institutes and clinical laboratories. French organizations increasingly integrate advanced cell isolation systems that support translational research, immunology studies, and therapeutic development activities.

Italy 🇮🇹

Laboratory Workflow Enhancement

Italy strengthens the cell separation market through expanding biomedical research and clinical laboratory modernization. Italian institutions increasingly invest in efficient cell isolation technologies that improve research reproducibility and support advanced diagnostic and therapeutic applications.

Japan 🇯🇵

Regenerative Medicine Support

Japan emphasizes cell separation technologies that strengthen regenerative medicine, stem cell research, and precision healthcare initiatives. Japanese research institutions and biotechnology companies increasingly adopt high-performance systems that improve sample quality and laboratory productivity.

South Korea 🇰🇷

Biotech Manufacturing Enablement

South Korea expands cell separation capabilities to support growing investments in biopharmaceutical production and advanced therapeutics. Korean organizations prioritize scalable separation platforms that streamline laboratory operations and enable consistent cell processing across development programs.

United States 🇺🇸

Cell Therapy Processing

The U.S. cell separation market is driven by expanding cell therapy development, regenerative medicine research, and biopharmaceutical manufacturing. Organizations prioritize automated separation technologies that improve processing efficiency, reproducibility, and scalability for advanced therapeutic applications.

Segment Analysis

Segment Leadership and Growth Trends

Cell Separation Market Share (%), by Cell Type, 2026

Animal Cells
Human Cells

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Cell Type Segment Analysis: Animal Cells (Largest Segment) vs Human Cells (Fastest-Growing Segment)

Animal cells accounted for the largest share of the cell separation market in 2026 at 56.57%, supported by their extensive use in research, drug development, disease modeling, and laboratory investigations. Animal-derived cell models are widely used to study biological processes and evaluate therapeutic approaches, creating sustained demand for reliable cell isolation and purification techniques. Research organizations also rely on separated cell populations to improve experimental consistency and enable more detailed analysis of cellular behavior. Continued activity in life sciences research and the use of animal models in biomedical investigations therefore reinforce the leading position of animal cell separation.

Human cells represent the fastest-growing segment as advances in personalized medicine, regenerative medicine, cell-based research, and disease investigation increase demand for highly purified human cell populations. Researchers require specific cell types to study human biology, identify disease mechanisms, develop therapies, and evaluate treatment responses. The increasing focus on patient-specific research and human-relevant experimental models is encouraging greater use of sophisticated cell separation workflows. Growing activity in cell-based applications and translational research is consequently accelerating demand for technologies capable of efficiently isolating human cells.

Technique Segment Analysis: Centrifugation (Largest Segment) vs Surface Marker (Fastest-Growing Segment)

Centrifugation led the cell separation market in 2026 with a 43.61% share, reflecting its established role as a practical and widely accessible method for separating cells according to physical properties such as density and size. The technique can be incorporated into numerous laboratory workflows and is commonly used for processing biological samples before downstream analysis or experimentation. Its familiarity, operational versatility, and compatibility with established laboratory equipment contribute to widespread utilization. Continued demand for efficient sample preparation across research and clinical laboratories supports centrifugation as a core cell separation technique.

Surface marker-based separation is the fastest-growing technique segment as researchers increasingly require highly specific isolation of distinct cell populations based on their biological characteristics. This approach can selectively identify and enrich cells expressing particular surface markers, making it valuable for advanced research involving heterogeneous cell populations. Growing interest in immunology, cancer research, cell therapy, and precision medicine is increasing the need for more selective separation methods. As biological investigations become more focused on individual cell populations, surface marker technologies are gaining importance for high-specificity cell isolation.

Segment Sub-Segment Largest Segment Fastest Growing
Cell Type Human Cells, Animal Cells Animal Cells Human Cells
Technique Centrifugation, Surface Marker, Filtration Centrifugation Surface Marker
End-Use Research Laboratories and Institutes, Biotechnology and Biopharmaceutical Companies, Hospitals and Diagnostic Laboratories, Cell Banks Research Laboratories and Institutes Biotechnology and Biopharmaceutical Companies
Application Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, Therapeutics Biomolecule Isolation Biomolecule Isolation
Product Consumables, Instruments Consumables Instruments
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Top players in the cell separation market:

1. Thermo Fisher Scientific Inc. (United States)

2. Danaher Corporation (United States)

3. Becton Dickinson and Company (United States)

4. STEMCELL Technologies Inc. (Canada)

5. Merck KGaA (Germany)

6. Bio-Rad Laboratories Inc. (United States)

7. Terumo Corporation (Japan)

8. Agilent Technologies Inc. (United States)

9. Corning Incorporated (United States)

10. Akadeum Life Sciences Inc. (United States)

Innovation-driven competition in the cell separation market is accelerating as organizations invest heavily in technologies that enhance cell purity, recovery rates, and processing efficiency. Automated systems and advanced separation techniques are gaining traction due to rising demand from regenerative medicine and cell therapy applications. The cell separation market is also benefiting from expanded research activities and workflow optimization initiatives aimed at improving scalability and laboratory productivity.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Thermo Fisher Scientific Inc. (United States)
Danaher Corporation (United States)
Becton Dickinson and Company (United States)
STEMCELL Technologies Inc. (Canada)
Merck KGaA (Germany)
Bio-Rad Laboratories Inc. (United States)
Terumo Corporation (Japan)
Agilent Technologies Inc. (United States)
Corning Incorporated (United States)
Akadeum Life Sciences Inc. (United States).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Thermo Fisher Scientific Dec-25 Thermo Fisher Scientific launched the CTS Rotea modular closed cell processing system to automate cell therapy manufacturing workflows. The hardware launch scales down closed-system fluidics for clinical-to-commercial applications, driving industrial standardization in cell separation and continuous processing within advanced cellular therapeutic manufacturing environments.
ScaleReady Jul-25 ScaleReady awarded a strategic G-Rex manufacturing grant to Immuneel Therapeutics to scale the localized production of autologous CAR-T cell therapies in India. The infrastructure funding supports clinical cell processing workflows and industrial bioreactor utilization, expanding scalable cell separation and therapeutic access in developing healthcare markets.
CGBio Jun-25 CGBio established a localized joint venture, Sol Cent Bio Co. Ltd., in China to expand its infrastructure footprint across regenerative medicine and cell therapy markets. The strategic cross-border entity focuses on optimizing regional supply chains and accelerating the commercialization of cell-based solutions in high-growth Asian markets.
Simple Planet Sep-24 Simple Planet secured an $8 million South Korean government grant to scale corporate cell culture systems and advance regulatory filings for its cultivated meat ingredients. The capital injection accelerates the commercial scaling of corporate cellular agriculture platforms, directly advancing industrial cell separation and biomass processing technologies.
NanoCellect Biomedical Jul-24 NanoCellect Biomedical introduced the VERLO Image-Guided Cell Sorter, a microfluidic device integrating traditional flow cytometry with twelve imaging channels. Operating at low fluidic pressure, the system commercializes label-free stem cell and immune cell isolation based on spatial morphologic features, protecting sensitive engineered lines from shear stress.
Akadeum Life Sciences May-23 Akadeum Life Sciences launched a series of microbubble-based cell isolation kits, introducing a direct leukopak human immune cell isolation platform alongside T-cell activation and expansion protocols. The product rollout utilizes buoyancy-activated sorting technology to eliminate standard pre-processing lysis, washing, and magnetic columns to accelerate cell therapy research.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Cell Separation Market — Custom Segments

Segment Sub-Segment
Automation Level Manual, Semi-Automated, Fully Automated
Throughput Low Throughput, Medium Throughput, High Throughput
Sample Source Blood & Bone Marrow, Tissue-Derived Samples, Cell Culture & Other Biological Samples

Cell Separation Market — Custom TOC

Custom Chapter Custom Details
Cell Therapy Manufacturing Capacity and Demand Assessment
  • Cell Therapy Manufacturing Capacity Development
  • Cell Separation Requirements Across Production Workflows
  • Scale-Up and Process Standardization Priorities
  • Manufacturing-Driven Demand Opportunities
Bioprocess Outsourcing and CDMO Opportunity Landscape
  • Outsourcing Trends Across Cell-Based Manufacturing
  • CDMO Requirements for Cell Separation Processes
  • In-House Versus Outsourced Processing Considerations
  • Emerging Outsourcing Opportunity Areas
Laboratory Automation Adoption and Procurement Trends
  • Automation Across Cell Separation Workflows
  • Throughput, Reproducibility and Workflow Requirements
  • Automated System Procurement Criteria
  • Adoption Drivers and Implementation Priorities

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the market valuation of cell separation?

The market valuation of the cell separation is USD 12.18 billion in 2027.

How is the cell separation industry size expected to evolve during the forecast period?

Cell Separation Market size was worth USD 11.2 billion in 2026 and is expected to grow at a 10.36% CAGR between 2027 and 2036, reaching USD 30.01 billion by 2036.

How is personalized medicine influencing technology adoption in the cell separation market?

Personalized medicine requires high-purity, viable cell populations from patient-derived samples, driving investment in advanced cell isolation platforms that improve sample integrity, support downstream workflows, and deliver consistent therapeutic and diagnostic outcomes.

Why is automation becoming a strategic priority in the cell separation market?

Growing research activity and biotechnology startup investment are increasing demand for automated platforms that improve reproducibility, reduce operator variability, support scalable workflows, and accelerate commercialization across cell therapy, regenerative medicine, and advanced diagnostics.

Why do animal cells account for the largest share of the cell separation market?

Animal cells held a 56.57% share in 2026 due to their extensive use in routine laboratory workflows, preclinical research, and established experimental models supported by standardized protocols and consistent availability.

What is driving the rapid growth of surface marker-based cell separation techniques?

Surface marker techniques are growing fastest because they enable more precise isolation of specific cell populations, supporting targeted research applications that require higher-purity samples and greater analytical accuracy.

Why does North America lead the cell separation market?

North America captured a 38.73% share in 2026, driven by strong biotechnology infrastructure, research funding, and consistent use of cell separation tools in clinical and laboratory workflows.

How is Asia Pacific shaping future growth in the cell separation market?

Asia Pacific is projected to grow at an 11.31% CAGR, supported by expanding biomedical research capacity, biopharmaceutical investment, and rising adoption of cell processing technologies.

Which companies dominate the cell separation landscape?

Major companies in the cell separation market include Thermo Fisher Scientific Inc. (United States), Danaher Corporation (United States), Becton, Dickinson and Company (United States), STEMCELL Technologies Inc. (Canada), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (United States), Terumo Corporation (Japan), Agilent Technologies, Inc. (United States), Corning Incorporated (United States), Akadeum Life Sciences, Inc. (United States).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →